{
    "meta": {
        "totalResults": 151,
        "from": 0,
        "originalQuery": "/resources?size=20&from=0&researchAreas=cancer_treatment&researchAreas=causes_of_cancer&researchAreas=cancer_diagnosis&researchAreas=cancer_statistics&researchAreas=bioinformatics"
    },
    "results": [
        {
            "id": 105,
            "title": "3D Slicer",
            "website": "https://www.slicer.org",
            "body": "<p>3D Slicer is an open-source software platform for medical image informatics, image processing, and three-dimensional visualization. Slicer brings free, powerful cross-platform processing tools to physicians, researchers, and the general public.</p>",
            "description": "<p>3D Slicer is an open-source software platform for medical image informatics, image processing, and three-dimensional visualization.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "screening_detection",
                    "label": "Screening & Detection"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                },
                {
                    "key": "cancer_diagnosis",
                    "label": "Cancer Diagnosis"
                }
            ],
            "researchTypes": [
                {
                    "key": "translational",
                    "label": "Translational"
                },
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "itcr",
                    "label": "Informatics Technology for Cancer Research (ITCR)"
                }
            ],
            "poCs": []
        },
        {
            "id": 258,
            "title": "Activities Completed over Time in 24 hours (ACT24)",
            "website": "https://dceg.cancer.gov/research/how-we-study/exposure-assessment/physical-activities-completed-over-time-24-hours-act-24",
            "body": "<p>Activities Completed over Time in 24 hours (ACT24) is a free, web-based tool to estimate daily summary values for physical activity and sedentary behavior, including time spent sitting and in different types and intensities of physical activity. ACT24 has been validated in studies of middle-aged and older adults and has been used to provide detailed portraits of human time use and energy expenditure at the population level. Researchers can register their projects, generate custom logins for participants to enter data via a secure participant site, and download data. An Application Programming Interface (API) is available to link ACT24 data to study management systems.</p>",
            "description": "<p>Activities Completed over Time in 24 hours (ACT24) is a free, web-based tool for epidemiologic, interventional, behavioral, or clinical research on energy expenditure. ACT24 estimates daily summary values for physical activity and sedentary behavior, including time spent sitting and in different types and intensities of physical activity, based on previous-day recall reporting from participants.</p>",
            "toolTypes": [
                {
                    "key": "community_research_tools",
                    "label": "Community Research Tools"
                },
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "causes_of_cancer",
                    "label": "Causes of Cancer"
                },
                {
                    "key": "cancer_prevention",
                    "label": "Cancer Prevention"
                },
                {
                    "key": "cancer_health_disparities",
                    "label": "Cancer Health Disparities"
                }
            ],
            "researchTypes": [
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                }
            ],
            "resourceAccess": {
                "type": "register",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dceg",
                    "label": "Division of Cancer Epidemiology and Genetics (DCEG)"
                },
                {
                    "key": "dccps",
                    "label": "Division of Cancer Control and Population Sciences (DCCPS)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": "Dr.",
                        "firstName": "Charles",
                        "middleName": null,
                        "lastName": "Matthews",
                        "suffix": null
                    },
                    "title": "Senior Investigator",
                    "phone": "240-276-7211",
                    "email": "matthewsce@mail.nih.gov"
                },
                {
                    "name": {
                        "prefix": "Dr.",
                        "firstName": "David",
                        "middleName": null,
                        "lastName": "Berrigan",
                        "suffix": null
                    },
                    "title": "Program Director",
                    "phone": "240-276-6752",
                    "email": "berrigad@mail.nih.gov"
                }
            ]
        },
        {
            "id": 170,
            "title": "Age Period Cohort Analysis Web Tool",
            "website": "https://dceg.cancer.gov/tools/analysis/apc",
            "body": "<p>Age–period–cohort (APC) analysis can inform registry-based studies of cancer incidence and mortality, but concerns about statistical identifiability and interpretability, as well as the learning curves of statistical software packages, have limited its uptake. This tool contains a panel of easy-to-interpret estimable APC functions and corresponding Wald tests in R code that can be accessed through a user-friendly Web tool.</p>",
            "description": "<p>Age Period Cohort Analysis Web Tool is a panel of easy-to-interpret estimable age–period–cohort (APC) functions and corresponding Wald tests in R code that can be accessed through a user-friendly webtool.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "causes_of_cancer",
                    "label": "Causes of Cancer"
                }
            ],
            "researchTypes": [
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                }
            ],
            "resourceAccess": {
                "type": null,
                "notes": "License Agreement"
            },
            "doCs": [
                {
                    "key": "dceg",
                    "label": "Division of Cancer Epidemiology and Genetics (DCEG)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": null,
                        "middleName": null,
                        "lastName": null,
                        "suffix": null
                    },
                    "title": null,
                    "phone": null,
                    "email": "NCIAPCWebToolAdmin@mail.nih.gov"
                }
            ]
        },
        {
            "id": 93,
            "title": "AIDS Antiviral Screen Data",
            "website": "https://wiki.nci.nih.gov/display/NCIDTPdata/AIDS+Antiviral+Screen+Data",
            "body": "<p>The DTP AIDS Antiviral Screen has checked tens of thousands of compounds for evidence of anti-HIV activity. Screening results and chemical structural data on compounds that are not covered by a confidentiality agreement are available.</p>",
            "description": "<p>This resource provides access to results and chemical structural data on compounds checked by the Developmental Therapeutics Program (DTP) AIDS Antiviral Screen.</p>",
            "toolTypes": [
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                },
                {
                    "key": "lab_tools",
                    "label": "Lab Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "screening_detection",
                    "label": "Screening & Detection"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                },
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 250,
            "title": "Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe)",
            "website": "https://califano.c2b2.columbia.edu/aracne",
            "body": "<p>ARACNe uses microarray expression profiles to reconstruct tissue-specific gene regulatory transcriptional interactions in cellular networks. The method uses mutual information of two random variables to identify genes that are co-expressed, then applies the data processing inequality to filter out interactions that are likely to be indirect. This eliminates the vast majority of false-positive transcriptional interactions typically inferred by pairwise gene-expression correlation analysis. This tool could be used by researchers to determine novel driver genes and drug mechanisms of action.</p>",
            "description": "<p>ARACNe is an algorithm for inferring direct regulatory relationships between transcriptional regulator proteins and target genes.</p>",
            "toolTypes": [
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                },
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_biology",
                    "label": "Cancer Biology"
                },
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics"
                },
                {
                    "key": "bioinformatics",
                    "label": "Bioinformatics"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                },
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "ocg",
                    "label": "Office of Cancer Genomics (OCG)"
                },
                {
                    "key": "ccg",
                    "label": "Center for Cancer Genomics (CCG)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": "Dr.",
                        "firstName": "Andrea",
                        "middleName": null,
                        "lastName": "Califano",
                        "suffix": null
                    },
                    "title": "Clyde and Helen Wu Professor of Chemical and Systems Biology",
                    "phone": null,
                    "email": "ac2248@cumc.columbia.edu"
                }
            ]
        },
        {
            "id": 75,
            "title": "AMARETTO",
            "website": "http://portals.broadinstitute.org/pochetlab/amaretto.html",
            "body": "<p>AMARETTO is for multi-omics data fusion and reformulations for pan-etiology and pan-cancer applications. AMARETTO is an algorithm that integrates copy number, DNA methylation, and gene expression data to identify a set of driver genes by analyzing cancer samples and connects them to clusters of co-expressed genes.</p>",
            "description": "<p>AMARETTO is an algorithm that integrates copy number, DNA methylation, and gene expression data to identify a set of driver genes by analyzing cancer samples and connects them to clusters of co-expressed genes.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics"
                },
                {
                    "key": "causes_of_cancer",
                    "label": "Causes of Cancer"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "itcr",
                    "label": "Informatics Technology for Cancer Research (ITCR)"
                }
            ],
            "poCs": []
        },
        {
            "id": 154,
            "title": "Analytic Technique for Assessment of RNAi by Similarity (ATARiS)",
            "website": "https://www.broadinstitute.org/cancer/ataris",
            "body": "<p>RNAi reagents designed to target the same gene often induce different degrees of on-target and off-target gene suppression, resulting in inconsistent phenotypes. To address this, ATARiS tries to identify subsets of its RNAi reagents that produce a significantly similar phenotype across the screened smaples. This approach also computes a consistency score that represents the confidence that its observed phenotypic effects are the result of on-target gene suppression.</p>",
            "description": "<p>ATARiS is a computational method designed to analyze the off-target effects in the data generated from RNAi screens.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_biology",
                    "label": "Cancer Biology"
                },
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                },
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "register",
                "notes": null
            },
            "doCs": [
                {
                    "key": "ccg",
                    "label": "Center for Cancer Genomics (CCG)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": null,
                        "middleName": null,
                        "lastName": null,
                        "suffix": null
                    },
                    "title": null,
                    "phone": null,
                    "email": "ataris@broadinstitute.org"
                }
            ]
        },
        {
            "id": 83,
            "title": "Annual Report to the Nation on the Status of Cancer",
            "website": "https://seer.cancer.gov/report_to_nation/",
            "body": "<p>The report includes a special section to highlight a major topic in cancer surveillance. Recent topics include financial toxicity, progress toward Healthy People 2020 objectives, survival, prostate cancer, and molecular subtypes of breast cancer. This is an annual collaboration between NCI, North American Association of Central Cancer Registries, the Centers for Disease Control and Prevention, and the American Cancer Society. The agencies rotate between leading the report. Typically, the trends are by sex and race/ethnicity. The Surveillance, Epidemiology, and End Results (SEER) programwebsite hosts a microsite with summaries, factoids, links, and other shareable resources.</p>",
            "description": "<p>The Annual Report to the Nation is a publication that provides an update of rates for new cases and deaths, as well as trends, for the most common cancers in the United States.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_health_disparities",
                    "label": "Cancer Health Disparities"
                },
                {
                    "key": "cancer_survivorship",
                    "label": "Cancer Survivorship"
                },
                {
                    "key": "cancer_statistics",
                    "label": "Cancer Statistics"
                }
            ],
            "researchTypes": [
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dccps",
                    "label": "Division of Cancer Control and Population Sciences (DCCPS)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": "Kathy",
                        "middleName": null,
                        "lastName": "Cronin",
                        "suffix": null
                    },
                    "title": "Deputy Associate Director, Surveillance Research Program",
                    "phone": "240-276-6836",
                    "email": "cronink@mail.nih.gov"
                }
            ]
        },
        {
            "id": 10,
            "title": "Apache Clinical Text and Knowledge Extraction System (cTAKES)",
            "website": "http://ctakes.apache.org",
            "body": "<p>cTAKES extracts deep phenotypic information from the clinical narrative at the document, episode, and patient level. The final output is a Fast Healthcare Interoperability Resources (FHIR)-compliant, patient-level phenotypic summary which can be consumed by research warehouses or the DeepPhe native visualization tool.</p>",
            "description": "<p>cTAKES extracts deep phenotypic information from the clinical narrative at the document, episode, and patient level.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_diagnosis",
                    "label": "Cancer Diagnosis"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "itcr",
                    "label": "Informatics Technology for Cancer Research (ITCR)"
                }
            ],
            "poCs": []
        },
        {
            "id": 51,
            "title": "Baysian Phase II Single Arm Clinical Trials",
            "website": "https://brpnci.shinyapps.io/Phase2sim_survival_v1/",
            "body": "<p>For simulations of single-arm trials for treatment (T),  assume that one interim analysis is conducted after nti events have occurred. By generating nti exponentially distributed event times (with rate parameter log(2)/mt), the parameters for the posterior gamma distribution of λt can be updated as αt = 1+nti and βt = 0.001+Σxti where Σxti is calculated as the sum of the nti simulated event times. For the simulations, users should specify the observed values of nc, mc, assumed value for mt, nt and the proportion of total events after which the interim analysis is to be conducted. h, ε and the number of trials to simulate should also be specified by the user. It is assumed that every subject is followed until event occurrence.</p>",
            "description": "<p>This application supports the conduct of simulations for a single arm phase II clinical trial of a new treatment T with time to event outcome variable.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                },
                {
                    "key": "community_research_tools",
                    "label": "Community Research Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 52,
            "title": "Baysian Phase II Single Arm Clinical Trials",
            "website": "https://brpnci.shinyapps.io/Phase2sim_v1/",
            "body": "<p>The null hypothesis to be tested is that pt = pc against the alternative pt > pc.  If criteria for stopping at interim analysis are not met, additional accrual and outcome are simulated until a total of Nt patients are accrued to T. At the end of the trial, the posterior distribution of pt is updated again and the posterior probability pp_final that pt > pc is recomputed. If pp_final is ≥ 1- ε , then the null hypothesis is rejected, and superiority of T over C is declared. For the simulations, the user needs to specify the observed values for nc, xc, assumed values for pt, Nt and the proportion of total enrollment, after which the interim analysis is to be conducted. δ, ε and the number of trials to simulate are also specified by the user.</p>",
            "description": "<p>This application supports the conduct of simulations for a single-arm phase II clinical trial of a new treatment (T) with a binary outcome variable.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                },
                {
                    "key": "community_research_tools",
                    "label": "Community Research Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 39,
            "title": "Biomarker Stratified Randomized Design (Binary)",
            "website": "https://brb.nci.nih.gov/brb/samplesize/sdpap_binary.html",
            "body": "<p>A randomized trial comparing new treatment (T) to control (C) includes both classifier-positive and classifier-negative patients. This program presumes  availability of binary classifier for biomarker predictive of benefit for new treatment. Sample size calculation for three analysis plans are provided. The first analysis plan determines sample size for the overall test comparing T to C for all randomized patients at reduced two-sided level alpha.  The second determines sample size for comparing T to C in the classifier-positive subset at two-sided .05 level.  For the third plan, first test for interaction between size of treatment effect and subset (classifier + or classifier -). If the interaction is non-significant, just compare treatments overall at two-sided significance level .05, otherwise, compare treatments within subsets at two-sided .05 level.</p>",
            "description": "<p>This program performs stratified design with a prospective analysis plan and binary endpoint.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 40,
            "title": "Biomarker Stratified Randomized Design (Time-to-Event)",
            "website": "https://brb.nci.nih.gov/brb/samplesize/sdpap_survival.html",
            "body": "<p>A randomized trial comparing new treatment (T) to control (C) includes both classifier-positive and classifier-negative patients. The program presumes availability of time-to-event predictive of benefit for new treatment. Sample size calculation for three analysis plans are provided: A) Determine sample size for overall test comparing T to C for all randomized patients at reduced two-sided level alpha.  B) Determine sample size for comparing T to C in classifier positive subset at two-sided .05 level.  C) First test for interaction between size of treatment effect and subset (classifier + or classifier -). If interaction is non-significant, just compare treatments overall at two-sided significance level .05. Otherwise, compare treatments within subsets at two-sided .05 level.</p>",
            "description": "<p>This program performs stratified design with prospective analysis plan and time-to-event endpoint.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 41,
            "title": "Biomarker Targeted Randomized Design",
            "website": "https://brb.nci.nih.gov/brb/samplesize/td.html",
            "body": "<p>Targeted design randomizes only marker-positive patients to a treatment arm. Untargeted design does not measure the marker and randomizes all who otherwise are eligible. By inputting the probability of response for control arm, the proportion of patients who are classifier positive, the improvement in response probability for new treatment in classifier positive patients, the Improvement in response probability for new treatment in classifier negative patients, two-sided significance level, and power, this program calculates the total number of patients for untargeted design and randomized targeted design, as well as total number of patients screened for targeted design.</p>",
            "description": "<p>This program calculates the sample size for biomarker targeted randomized design with binary outcome endpoint.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                },
                {
                    "key": "community_research_tools",
                    "label": "Community Research Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 42,
            "title": "BRB-Array Tools",
            "website": "https://brb.nci.nih.gov/BRB-ArrayTools/",
            "body": "<p>BRB-ArrayTools was developed by professional statisticians experienced in the analysis of microarray data and involved in the development of improved methods for the design and analysis of microarray-based experiments. The analytic and visualization tools are integrated into Excel as an add-in. The analytic and visualization tools themselves are developed in the powerful R statistical system, in C and Fortran programs, and in Java applications. Visual Basic for Applications is the glue that integrates the components and hides the complexity of the analytic methods from the user. The system incorporates a variety of powerful analytic and visualization tools developed specifically for microarray data analysis.</p>",
            "description": "<p>BRB-Array Tools is an integrated package for the visualization and statistical analysis of microarray gene expression, copy number, methylation, and RNA-Seq data.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics"
                },
                {
                    "key": "bioinformatics",
                    "label": "Bioinformatics"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                },
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dctd",
                    "label": "Division of Cancer Treatment and Diagnosis (DCTD)"
                }
            ],
            "poCs": []
        },
        {
            "id": 6,
            "title": "Cancer and Phenomics Toolkit (CaPTK)",
            "website": "http://captk.projects.nitrc.org",
            "body": "<p>CaPTk is a tool that facilitates translation of highly sophisticated methods that help researchers gain a comprehensive understanding of the underlying mechanisms of cancer from medical imaging research to the clinic. It replicates basic interactive functionalities of radiological workstations and is distributed under a Berkeley Software Distribution (BSD)-style license.</p>",
            "description": "<p>CaPTk is a tool that facilitates translation of highly sophisticated methods that help researchers gain a comprehensive understanding of the underlying mechanisms of cancer from medical imaging research to the clinic.</p>",
            "toolTypes": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "screening_detection",
                    "label": "Screening & Detection"
                },
                {
                    "key": "cancer_diagnosis",
                    "label": "Cancer Diagnosis"
                }
            ],
            "researchTypes": [
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "itcr",
                    "label": "Informatics Technology for Cancer Research (ITCR)"
                }
            ],
            "poCs": []
        },
        {
            "id": 180,
            "title": "Cancer Epidemiology Descriptive Cohort Database (CEDCD)",
            "website": "https://cedcd.nci.nih.gov/",
            "body": "<p>The CEDCD contains descriptive information about cohort studies that follow groups of persons over time for cancer incidence, mortality, and other health outcomes. The CEDCD is a searchable database that contains general study information (e.g., eligibility criteria and size), the type of data collected at baseline, cancer sites, number of participants diagnosed with cancer, and biospecimen information. All data included in this database are aggregated for each cohort; there are no individual-level data. The goal of the CEDCD is to facilitate collaboration and highlight the opportunities for research within existing cohort studies.</p>\n<p>Information in the CEDCD has been provided with approval from the cohort principal investigators.</p>",
            "description": "<p>The CEDCD is a searchable database that contains information about cohort studies that follow groups of persons over time for cancer incidence, mortality, and other health outcomes.</p>",
            "toolTypes": [
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "causes_of_cancer",
                    "label": "Causes of Cancer"
                }
            ],
            "researchTypes": [
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dccps",
                    "label": "Division of Cancer Control and Population Sciences (DCCPS)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": "Joanne",
                        "middleName": null,
                        "lastName": "Elena",
                        "suffix": null
                    },
                    "title": "Program Director, Clinical and Translational Epidemiology Branch",
                    "phone": "240-276-6818",
                    "email": "elenajw@mail.nih.gov"
                }
            ]
        },
        {
            "id": 134,
            "title": "Cancer Genome Characterization Initiative (CGCI) Data Matrix",
            "website": "https://ocg.cancer.gov/programs/cgci/data-matrix",
            "body": "<p>CGCI Data Matrix contains whole-genome and transcriptomic sequencing from Burkitt lymphoma, HIV- associated tumors, medulloblastoma, and non-Hodgkin lymphoma types of cancers. Researchers can access up to four levels of data, from primary through higher level summary data for the molecular platform employed. To protect the privacy of patients, some clinical and genetic data require approval to access through NCBI’s database for Genotypes and Phenotypes (dbGAP; <a href=\"http://www.ncbi.nlm.nih.gov/gap\">http://www.ncbi.nlm.nih.gov/gap</a>).</p>",
            "description": "<p>The CGCI Data Matrix hosts genomic profiles (molecular characterization and sequence data) and clinical data for rare adult and  pediatric tumor types.</p>",
            "toolTypes": [
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_biology",
                    "label": "Cancer Biology"
                },
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                }
            ],
            "researchTypes": [
                {
                    "key": "basic",
                    "label": "Basic"
                },
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "ccg",
                    "label": "Center for Cancer Genomics (CCG)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": null,
                        "middleName": null,
                        "lastName": null,
                        "suffix": null
                    },
                    "title": null,
                    "phone": null,
                    "email": "ocg@mail.nih.gov"
                }
            ]
        },
        {
            "id": 54,
            "title": "Cancer Intervention and Surveillance Modeling Network",
            "website": "https://cisnet.cancer.gov/",
            "body": "<p>CISNET is a consortium of NCI-sponsored investigators who use statistical and simulation modeling to examine the potential impacts of prevention, screening, and treatment on cancer incidence and mortality. These models can then project future trends and help determine optimal cancer control strategies. These models can also be used to guide public health research and priorities. Established in 2000, CISNET comprises nine cancer site groups: breast, prostate, colorectal, lung, cervical, gastric, uterine, bladder, and multiple myeloma. Many of the resources generated by the CISNET consortium are freely available on the website. Additionally, CISNET invites inquiries from outside groups regarding collaborations on cancer control issues that are amenable to modeling.</p>",
            "description": "<p>CISNET is a consortium of NCI-sponsored investigator who use statistical and simulation modeling to predict the effects of cancer interventions.</p>",
            "toolTypes": [
                {
                    "key": "networks_consortiums",
                    "label": "Networks/Consortiums"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_health_disparities",
                    "label": "Cancer Health Disparities"
                },
                {
                    "key": "screening_detection",
                    "label": "Screening & Detection"
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                },
                {
                    "key": "cancer_prevention",
                    "label": "Cancer Prevention"
                }
            ],
            "researchTypes": [
                {
                    "key": "clinical",
                    "label": "Clinical"
                },
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                },
                {
                    "key": "translational",
                    "label": "Translational"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dccps",
                    "label": "Division of Cancer Control and Population Sciences (DCCPS)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": "Eric (Rocky)",
                        "middleName": null,
                        "lastName": "Feuer",
                        "suffix": null
                    },
                    "title": "Chief, Statistical Research and Applications Branch, Surveillance Research Program",
                    "phone": "240-276-6772",
                    "email": "feuerr@mail.nih.gov"
                },
                {
                    "name": {
                        "prefix": null,
                        "firstName": "Susan",
                        "middleName": null,
                        "lastName": "Scott",
                        "suffix": null
                    },
                    "title": "Public Health Advisor, Surveillance Research Program",
                    "phone": "240-276-6951",
                    "email": "scotts2@mail.nih.gov"
                }
            ]
        },
        {
            "id": 125,
            "title": "Cancer Prevalence and Cost of Care Projections",
            "website": "https://costprojections.cancer.gov/",
            "body": "<p>This website provides tables and graphs showing cancer prevalence and costs of cancer care projected through 2020. Using Surveillance, Epidemiology, and End Results (SEER) data for incidence and survival in combination with Census data, the website has prevalence information by cancer site as well as for all sites combined. It also uses Medicare data to calculate the annualized mean net costs of care per patient. Users can see how much cancer care for each type costs the nation as a whole. Graphs have features such as breakdowns by phase of treatment as well.</p>",
            "description": "<p>This website provides tables and graphs showing cancer prevalence and costs of cancer care projected through 2020 by cancer site and for all sites combined.</p>",
            "toolTypes": [
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases"
                },
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools"
                }
            ],
            "toolSubtypes": null,
            "researchAreas": [
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment"
                },
                {
                    "key": "cancer_statistics",
                    "label": "Cancer Statistics"
                },
                {
                    "key": "cancer_public_health",
                    "label": "Cancer & Public Health"
                }
            ],
            "researchTypes": [
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic"
                }
            ],
            "resourceAccess": {
                "type": "open",
                "notes": null
            },
            "doCs": [
                {
                    "key": "dccps",
                    "label": "Division of Cancer Control and Population Sciences (DCCPS)"
                }
            ],
            "poCs": [
                {
                    "name": {
                        "prefix": null,
                        "firstName": "Angela",
                        "middleName": null,
                        "lastName": "Mariotto",
                        "suffix": null
                    },
                    "title": "Chief, Data Analytics Branch, Surveillance Research Program",
                    "phone": "240-276-6698",
                    "email": "mariotta@mail.nih.gov"
                }
            ]
        }
    ],
    "facets": [
        {
            "title": "Research Area",
            "param": "researchAreas",
            "items": [
                {
                    "key": "cancer_biology",
                    "label": "Cancer Biology",
                    "count": 102,
                    "selected": false
                },
                {
                    "key": "cancer_omics",
                    "label": "Cancer Omics",
                    "count": 92,
                    "selected": false
                },
                {
                    "key": "cancer_treatment",
                    "label": "Cancer Treatment",
                    "count": 82,
                    "selected": true
                },
                {
                    "key": "screening_detection",
                    "label": "Screening & Detection",
                    "count": 33,
                    "selected": false
                },
                {
                    "key": "cancer_health_disparities",
                    "label": "Cancer Health Disparities",
                    "count": 31,
                    "selected": false
                },
                {
                    "key": "causes_of_cancer",
                    "label": "Causes of Cancer",
                    "count": 29,
                    "selected": true
                },
                {
                    "key": "cancer_public_health",
                    "label": "Cancer & Public Health",
                    "count": 24,
                    "selected": false
                },
                {
                    "key": "cancer_diagnosis",
                    "label": "Cancer Diagnosis",
                    "count": 23,
                    "selected": true
                },
                {
                    "key": "cancer_prevention",
                    "label": "Cancer Prevention",
                    "count": 21,
                    "selected": false
                },
                {
                    "key": "cancer_statistics",
                    "label": "Cancer Statistics",
                    "count": 21,
                    "selected": true
                },
                {
                    "key": "bioinformatics",
                    "label": "Bioinformatics",
                    "count": 18,
                    "selected": true
                },
                {
                    "key": "cancer_survivorship",
                    "label": "Cancer Survivorship",
                    "count": 13,
                    "selected": false
                }
            ]
        },
        {
            "title": "Research Type",
            "param": "researchTypes",
            "items": [
                {
                    "key": "basic",
                    "label": "Basic",
                    "count": 74,
                    "selected": false
                },
                {
                    "key": "translational",
                    "label": "Translational",
                    "count": 74,
                    "selected": false
                },
                {
                    "key": "epidemiologic",
                    "label": "Epidemiologic",
                    "count": 40,
                    "selected": false
                },
                {
                    "key": "clinical_trials",
                    "label": "Clinical Trials",
                    "count": 34,
                    "selected": false
                },
                {
                    "key": "clinical",
                    "label": "Clinical",
                    "count": 9,
                    "selected": false
                }
            ]
        },
        {
            "title": "Tool Type",
            "param": "toolTypes",
            "items": [
                {
                    "key": "analysis_tools",
                    "label": "Analysis Tools",
                    "count": 77,
                    "selected": false
                },
                {
                    "key": "datasets_databases",
                    "label": "Datasets & Databases",
                    "count": 64,
                    "selected": false
                },
                {
                    "key": "lab_tools",
                    "label": "Lab Tools",
                    "count": 21,
                    "selected": false
                },
                {
                    "key": "community_research_tools",
                    "label": "Community Research Tools",
                    "count": 14,
                    "selected": false
                },
                {
                    "key": "networks_consortiums",
                    "label": "Networks/Consortiums",
                    "count": 8,
                    "selected": false
                },
                {
                    "key": "terminology",
                    "label": "Terminology",
                    "count": 3,
                    "selected": false
                },
                {
                    "key": "clinical_research_tools",
                    "label": "Clinical Research Tools",
                    "count": 1,
                    "selected": false
                }
            ]
        }
    ]
}